3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Primary Myelofibrosis
13
Myeloproliferative Disorders
9
Leukemia, Myeloid, Acute
8
Thrombocythemia, Essential
6
Polycythemia Vera
6
Myelodysplastic Syndromes
5
Leukemia
5
Recurrence
3
Neoplasms
3
Lymphoma, T-Cell
3
Graft vs Host Disease
3
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma
2
Leukemia, Prolymphocytic, T-Cell
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hematologic Neoplasms
2
Uveal Melanoma
1
Thalassemia
1
Targeted Therapy
1
Prostatic Neoplasms
1
Preleukemia
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Neoplasms by Histologic Type
1
Mycosis Fungoides
1
Multiple Myeloma
1
Mesothelioma
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Interventions
Tamoxifen
7
Specimen Handling
7
exemestane
3
Letrozole
3
Anastrozole
3
Radiotherapy, Intensity-Modulated
2
Radiotherapy, Conformal
2
Radiation Dose Hypofractionation
2
Biopsy
2
ruxolitinib
1
poly ICLC
1
fezolinetant
1
elacestrant
1
Testosterone
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Selective Estrogen Receptor Modulators
1
Radiotherapy
1
Radiation
1
Protons
1
Proton Therapy
1
Omacor
1
Neoadjuvant Therapy
1
Multicenter Studies as Topic
1
Metformin
1
Medicare
1
Mastectomy, Segmental
1
Mastectomy
1
Magnetic Resonance Spectroscopy
1
High-Energy Shock Waves
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Intraductal, Noninfiltrating
×
ruxolitinib
×
90 days
×
Clear all
NCT02928978
2026-04-13
TBCRC042
Baylor Breast Care Center
Phase 2
Completed
84 enrolled